How the key proteins behind autosomal dominant polycystic kidney disease work
Structural Mechanisms of Polycystic Kidney Disease Proteins
This project looks at the shapes and assembly of the proteins that cause autosomal dominant polycystic kidney disease to help people with ADPKD.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Utah State Higher Education System--University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11321734 on NIH RePORTER |
What this research studies
I would describe this as lab research that aims to reveal the three-dimensional shapes and how PKD1, PKD2, and related polycystin proteins fit together in tiny cell structures called primary cilia. The team uses biochemical assays, structural imaging, and model systems to see how mutations change protein assembly and channel function. They also study related family members (like PKD1L1 and PKD2L2) that affect development and reproduction to broaden the picture. The work connects genetic changes found in people with ADPKD to specific molecular problems in the proteins.
Who could benefit from this research
Good fit: People with autosomal dominant polycystic kidney disease or a strong family history of ADPKD are the population most directly related to this research.
Not a fit: Patients whose kidney disease is caused by non-PKD genes or by unrelated conditions are unlikely to see direct benefit from these findings in the near term.
Why it matters
Potential benefit: If successful, this work could point to new drug targets or biomarkers that might slow cyst growth or guide personalized treatments for ADPKD patients.
How similar studies have performed: Previous genetic and functional studies have linked PKD1 and PKD2 to ADPKD, but high-resolution structures and detailed assembly mechanisms remain largely uncharacterized.
Where this research is happening
Salt Lake City, United States
- Utah State Higher Education System--University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Cao, Erhu — Utah State Higher Education System--University of Utah
- Study coordinator: Cao, Erhu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.